- Home
- EIC
as 11-20-2024 4:00pm EST
Eagle Point Income Co Inc is a closed-end management investment company. Its primary investment objective is to generate high current income, with a secondary objective to generate capital appreciation.
| Founded: | N/A | Country: | United States |
| Employees: | N/A | City: | N/A |
| Market Cap: | 268.2M | IPO Year: | 2019 |
| Target Price: | N/A | AVG Volume (30 days): | 116.0K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | Dividend Payout Frequency: | Monthly | |
| EPS: | 0.80 | EPS Growth: | N/A |
| 52 Week Low/High: | $13.00 - $16.48 | Next Earning Date: | 11-14-2023 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Eagle Point Income Company Inc. News
EIC Breaking Stock News: Dive into EIC Ticker-Specific Updates for Smart Investing
Business Wire
7 days ago
Eagle Point Income Company Inc. Announces Third Quarter 2024 Financial Results
Business Wire
15 days ago
Eagle Point Income Company Inc. Announces First Quarter 2025 Common and Preferred Distributions
Business Wire
20 days ago
Eagle Point Income Company Inc. Schedules Release of Third Quarter 2024 Financial Results on Thursday, November 14, 2024
Thomson Reuters StreetEvents
3 months ago
Q2 2024 Eagle Point Income Company Inc Earnings Call
Business Wire
3 months ago
Eagle Point Income Company Inc. Announces Second Quarter 2024 Financial Results
Business Wire
4 months ago
Eagle Point Income Company Inc. Announces Fourth Quarter 2024 Common and Preferred Distributions
Business Wire
4 months ago
Eagle Point Income Company Inc. Schedules Release of Second Quarter 2024 Financial Results on Tuesday, August 6, 2024
Yahoo Finance Video
5 months ago
FDA panel votes to recommend Eli Lilly's Alzheimer's drug
Compare EIC vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "EIC Eagle Point Income Company Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.